HomeopathyPub Date : 2024-11-01Epub Date: 2024-10-21DOI: 10.1055/s-0044-1791285
Robert T Mathie
{"title":"Homeopathy's Enhanced Scope and Recognition.","authors":"Robert T Mathie","doi":"10.1055/s-0044-1791285","DOIUrl":"https://doi.org/10.1055/s-0044-1791285","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association between Acute and Chronic Inflammatory States: A Case-Control Study.","authors":"Seema Mahesh, Mahesh Mallappa, Vitalie Vacaras, Viraj Shah, Elena Serzhantova, Nadezhda Kubasheva, Dmitriy Chabanov, Dionysios Tsintzas, Latika Jaggi, Atul Jaggi, George Vithoulkas","doi":"10.1055/s-0043-1777119","DOIUrl":"10.1055/s-0043-1777119","url":null,"abstract":"<p><strong>Background: </strong>Fever is the hallmark of efficient acute inflammatory response, which may be disrupted in chronic inflammatory conditions. The \"continuum theory\" proposes that the return of acute inflammatory states with high fever predicts improvement in chronic diseases during treatment. Our objective was to investigate the observation made, during classical homeopathic treatment, that such an association exists between chronic inflammation and efficient acute inflammation.</p><p><strong>Methods: </strong>In a case-control study, the reports of patients diagnosed with chronic inflammatory conditions with at least 6 months of follow-up under homeopathic treatment were retrospectively sampled from homeopathic medical practices from Greece, India, Romania and Russia. Twenty patients who improved under homeopathic treatment and 20 age-matched controls of those who did not improve were selected. The occurrence of common acute infectious diseases with fever during the follow-up period was investigated.</p><p><strong>Results: </strong>The average age of the cases and controls was 28.4 (SD: 16.64) and 27.9 (SD: 17.19) years respectively. 18/20 cases and 4/20 controls developed common infectious diseases with fever. Cramer's V co-efficient value was found to be 0.551 (<i>p</i> < 0.01), indicating that improvement was more in patients with fever than without. Odds ratio of improving with respect to development of acute infectious diseases was 36.0 (95% CI: 5.8 to 223.5). The binary logistic regression model indicated significant contribution of occurrence of acute infections with fever as a predictor for improvement in chronic inflammatory disease.</p><p><strong>Conclusions: </strong>Classical homeopathic clinical observations indicate an association between chronic inflammatory status in the body and the ability to mount efficient acute inflammation. In this case-control study, the occurrence of common infections with fever during treatment heralded improvement in chronic inflammatory disease. Further powered studies are necessary to substantiate this finding.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139711985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-11-01Epub Date: 2024-01-30DOI: 10.1055/s-0043-1776908
Nisanth K M Nambison, Narendra Sharma, Abhishek D Dwivedi, Nisha Chakravarty
{"title":"Individualized Homeopathic and Organopathic Supportive Management of Sickle Cell Disorder: A Case Series of Six Patients from a Particularly Vulnerable Tribal Group in India.","authors":"Nisanth K M Nambison, Narendra Sharma, Abhishek D Dwivedi, Nisha Chakravarty","doi":"10.1055/s-0043-1776908","DOIUrl":"10.1055/s-0043-1776908","url":null,"abstract":"<p><strong>Background: </strong>Sickle cell disorder (SCD) is a hereditary blood disease characterized by an abnormality in the oxygen-carrying protein hemoglobin present in red blood cells. Genetic abnormality causes these cells to become sickle-shaped, with shorter lifespan. Vaso-occlusive crisis is a major symptom of SCD: it is a sudden and severe episode of pain, and occurs when sickle-shaped cells block blood flow. This blockage can lead to tissue damage, inflammation and pain.</p><p><strong>Objectives: </strong>This case series aims to observe the clinical outcomes from prescribing individualized homeopathic medicines along with organopathic supportive medicine in the management of SCD through the analysis of case studies of six patients from a particularly vulnerable tribal group (PVTG) in India that manifests genetic predisposition for the disease.</p><p><strong>Method: </strong>The patients were administered individualized homeopathic and organopathic supportive medicines, after a comprehensive door-to-door survey and subsequent screening, conducted between October 2020 and May 2023 in the Dindori and Mandla districts of the central Indian state, Madhya Pradesh. Clinical symptoms, laboratory parameters including hemoglobin, along with scores from a visual analogue scale (VAS) for pain and from the World Health Organization Quality of Life (WHOQoL) Questionnaire, were determined.</p><p><strong>Results: </strong>Individualized homeopathic and organopathic supportive management led to improvements in clinical symptoms for all six patients. Laboratory test results showed a statistically significant increase in hemoglobin level associated with treatment. The VAS for pain indicated decreased pain frequency and severity. WHOQoL scores also improved, indicating enhanced well-being for each patient. No adverse effects were reported during treatment.</p><p><strong>Conclusion: </strong>This study suggests that individualized homeopathic medicine and organopathic supportive management have a beneficial role in managing SCD and may be valuable in the context of PVTGs in India. To establish a more comprehensive understanding of its efficacy, further studies should involve larger cohorts to allow for a thorough evaluation, including comparative analyses with standard therapies.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study.","authors":"Anupriya Chaudhary, Debadatta Nayak, Swati Pandey, Vipul Shastri, Madhuri Kamble, Vidya Pendse, Vismay Prajapati, Brijesh Vaidya, Heenal Rohit, Swaroopa Beedmani, Nutan Presswala, Tejaswini Patole, Ramesh Bawaskar, Vaishali Shinde, Mohua Datta, Gunjan Rai, Umakanta Prusty, Partha Pratim Pal, Siva Prasad Goli, Amulya Ratna Sahoo, K C Muraleedharan, Pooja Prakash, Ashish Mahajan, Anuradha Singh, Reetha Krishnan, Navin Pawaskar, Amit Srivastava, Gouri Devi Ningthoujam, Ravi Kumar Sadarla, Ranjit Sonny, Liyi Karso, Subhamoy Sarkar, Sunil Prasad, Ashish Kumar Shrivastava, Avinash Kumar, Nitesh Kumar, Ch Raveendar, Bsj Raja Kumar, Vspk Sastry, Asha Dasari, K Samson Sundeep, Subhash Kaushik, Padmalaya Rath, Shweta Gautam, Ratan Chandra Shil, Trupti Laxmi Swain, G Ravi Chandra Reddy, S Pradeep, S Stevenson, Gurudev Choubey, Lipipushpa Debata, Anil Khurana","doi":"10.1055/s-0044-1779693","DOIUrl":"10.1055/s-0044-1779693","url":null,"abstract":"<p><strong>Background: </strong>Prior vaccination is often studied for its impact on individuals' post-infection prognosis. Ayurveda, Yoga, Unani, Siddha and Homeopathy (AYUSH) medicines, advised by the Government of India as prophylaxis during the first wave of the coronavirus disease 2019 (COVID-19) pandemic, were consumed by the masses in 2020. A study was therefore undertaken to observe any association between the prior usage of AYUSH prophylactic medicines and post-infection severity as reported by recovered COVID-19 individuals.</p><p><strong>Methods: </strong>This was a retrospective, multi-centre, cohort study conducted in 21 cities of India from 5th August to 30th November 2020. Data from recovered COVID-19 patients, of either sex or any age, captured information about AYUSH prophylactic medicines intake prior to infection, disease severity, symptomatology, duration of complaints, etc. The study participants were grouped into AYUSH intake and non-intake. Primary composite outcome was the disease clinical course. Secondary clinical outcomes were the rate of and time to clinical recovery.</p><p><strong>Results: </strong>Data of 5,023 persons were analysed. Ayurveda or homeopathic prophylactic medicines were consumed by more than half of the study participants: that is, 56.85% (<i>n</i> = 1,556) and 56.81% (<i>n</i> = 1,555) respectively. The overall adjusted protective effect (PE) of AYUSH prophylactic intake against moderate/severe forms of COVID-19 disease was 56.7% (95% confidence interval [CI], 48.7 to 63.50; <i>p</i> < 0.001). Adjusted PE for homeopathy and Siddha was 52.9% (95% CI, 42.30 to 61.50; <i>p</i> < 0.001) and 59.8% (95% CI, 37.80 to 74.10; <i>p</i> < 0.001), respectively. A statistically significant association was found between AYUSH prophylactic medicine intake and clinical recovery more frequently by the 3rd day of illness (χ<sup>2</sup> = 9.01; <i>p</i> = 0.002). Time to resolution of symptoms in the AYUSH intake group was on average 0.3 days earlier than in the non-intake group (<i>p</i> = 0.002).</p><p><strong>Conclusion: </strong>AYUSH prophylactics were associated with statistically significant levels of protection against COVID-19 disease severity. Amongst these, previous intake of homeopathy or Siddha medicines was associated with some protection against moderate/severe illness and with a somewhat quicker clinical recovery. Prospective studies with experimental research design are needed to validate the findings of this study.</p><p><strong>Study registration: </strong>Clinical Trials Registry-India (CTRI/2020/08/027000).</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-11-01Epub Date: 2024-03-28DOI: 10.1055/s-0043-1778066
Giuliano Pereira de Barros, Denise Pereira Leme, Patrizia Ana Bricarello
{"title":"Homeopathic Pyrogenium Ointment as Adjuvant in Treatment of Traumatic and Infected Myiasis by Cochliomyia Hominivorax (Diptera: Calliphoridae) in Sheep: A Case Series.","authors":"Giuliano Pereira de Barros, Denise Pereira Leme, Patrizia Ana Bricarello","doi":"10.1055/s-0043-1778066","DOIUrl":"10.1055/s-0043-1778066","url":null,"abstract":"<p><strong>Background: </strong>The blowfly <i>Cochliomyia hominivorax</i> (Diptera: Calliphoridae) causes traumatic myiasis in farm animals, with deeply embedded larvae that lead to serious tissue damage and sometimes death. Treating this form of myiasis is difficult, often resulting in poor outcomes. As a homeopathic preparation that can mimic traumatic myiasis symptoms, <i>Pyrogenium</i> could potentially supplement treatment. This study aimed to describe the adjuvant effect that a <i>Pyrogenium</i> ointment might have in the treatment of sheep with traumatic myiasis.</p><p><strong>Patients: </strong>The study reports a homeopathic adjuvant treatment with <i>Pyrogenium</i> 12cH ointment in six sheep with traumatic and infected myiasis. Daily clinical examinations were performed to monitor the evolution of the health of animals. <i>Pyrogenium</i> 12cH ointment was applied topically on the wounds, after cleaning and mechanical removal of the larvae from the lesion. Blood samples were collected for blood counts, and wound exudate samples were obtained for bacteriological examination before and after wound treatment.</p><p><strong>Results: </strong>The ointment of <i>Pyrogenium</i> 12cH limited the development of parasitic larvae and was associated with the repair of tissue losses resulting from the myiases and with subsequent wound healing, together with control of fever and local inflammation.</p><p><strong>Conclusion: </strong>Homeopathic <i>Pyrogenium</i> 12cH, formulated as an ointment, may be a useful new and adjuvant therapeutic option for treating traumatic and infected myiasis in animals.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-11-01Epub Date: 2024-03-20DOI: 10.1055/s-0043-1778062
Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Helen Nogueira Carrer, Deise Lilian Costa Dias, José Nelson Martins Diniz, Manoela Gomes Grossi, Neli Aparecida Martins Sugimoto, Edson Zangiacomi Martinez
{"title":"Homeopathy for Chronic Non-specific Low Back Pain: Study Protocol for a Randomized, Double-Blind, Crossover, Placebo-Controlled Clinical Trial Investigating the Efficacy of the Biotherapic Lumbar Vertebra (The BIOVERT Trial).","authors":"Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Helen Nogueira Carrer, Deise Lilian Costa Dias, José Nelson Martins Diniz, Manoela Gomes Grossi, Neli Aparecida Martins Sugimoto, Edson Zangiacomi Martinez","doi":"10.1055/s-0043-1778062","DOIUrl":"10.1055/s-0043-1778062","url":null,"abstract":"<p><strong>Background: </strong>Chronic non-specific low back pain (CNSLBP) lacks identifiable anatomical pathology and effective pharmacological treatment. Alternative approaches in homeopathy, specifically clinical homeopathy, utilize ultra-diluted (potentized) biological products. In Brazil, standardized biotherapics from sheep tissues, particularly fifty-millesimal (LM) potencies of sheep <i>Lumbar Vertebra</i>, have shown promise in alleviating CNSLBP.</p><p><strong>Objectives: </strong>Our objective is to present the study protocol of a clinical trial that will assess the efficacy and safety of the biotherapic <i>Lumbar Vertebra</i> LM2 in the short-term management of CNSLBP and to estimate its therapeutic duration.</p><p><strong>Methods: </strong>A randomized, double-blind, crossover, placebo-controlled clinical trial spanning 8 weeks per participant was designed. Participants will include 120 individuals (aged 20 to 60 years) with clinically diagnosed CNSLBP by the study's physiotherapist. Exclusion criteria are radicular pain, signs of radiculopathy, specific lumbar spine disorders, pregnancy, or puerperium (up to 60 days after delivery). The medical intervention includes participants being randomly assigned to one of two treatment sequences: homeopathy-placebo or placebo-homeopathy. The treatments will consist of <i>Lumbar Vertebra</i> LM2 oral solution, topical cream, and indistinguishable placebos. Each treatment period will span 2 weeks, with a 4-week washout interval between them. Primary outcome is the assessment of changes in self-reported pain levels using the numeric rating scale (NRS) score, analyzed with a random effects model across both treatment periods. Secondary outcomes are assessment of changes in self-reported disability levels using the Oswestry Disability Index (ODI), analyzed with a random effects model across both treatment periods, and pain and disability variations, evaluated by the NRS score and ODI respectively, after the first and second treatment periods. Adverse events will be assessed at weeks 2 and 8. Pain medications will be used concomitantly. Adherence will be evaluated by the weight of medication returned/standard weight.</p><p><strong>Discussion: </strong>The BIOVERT (Bioactive Vertebra) trial protocol is designed to investigate a homeopathic strategy for short-term CNSLBP treatment. Favorable outcomes for homeopathy could prompt subsequent studies evaluating the long-term effectiveness of LM potencies of <i>Lumbar Vertebra</i> for CNSLBP.</p><p><strong>Trial registration: </strong>UMIN Clinical Trials Registry - ID: UMIN000051957.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness of Eupatorium Perfoliatum 30C in Preventing Dengue Fever-A Prospective, Community-Based, Open Label, Parallel Cohort Study in Delhi, India.","authors":"Debadatta Nayak, Lovepreet Kaur, Rupali Bhalerao, Karanpreet Nahar, Hanuman Ram, Pawan Sharma, Ankit Gupta, Smita Singh, Anil Khurana, Raj Kumar Manchanda","doi":"10.1055/s-0044-1788663","DOIUrl":"https://doi.org/10.1055/s-0044-1788663","url":null,"abstract":"<p><strong>Objective: </strong> The study was undertaken to evaluate the protective effect of <i>Eupatorium perfoliatum</i> (EP) 30C on the incidence of dengue fever.</p><p><strong>Design: </strong> This study was designed as a prospective, open label, parallel cohort study.</p><p><strong>Interventions: </strong> Participants were enrolled in two medicine cohort (MC) communities and one control cohort (CC) community. Participants in MC who were more than 5 years of age received four medicated globules and those aged between 1 and 5 years received two medicated globules of EP 30C once a week for 10 weeks. Participants in CC received no medical intervention. Both cohorts received information and educational material regarding dengue.</p><p><strong>Outcome measures: </strong> The primary outcome was incidence of dengue cases based on laboratory confirmation or the clinical definition of dengue as per the case definition notified by the National Vector-Borne Disease Control Program, Government of India, during the 14 weeks of intervention and observation.</p><p><strong>Results: </strong> The analysis included 20,607 participants residing in three slums of Delhi, of which MC and CC included 15,298 and 5,309 participants respectively. The overall protective effect of EP 30C in MC against probable/laboratory-confirmed dengue was 59.59% (95% confidence interval [CI], 50.74 to 66.85, <i>p</i> = 0.0001). The overall protective effect of EP 30C against laboratory-confirmed dengue was 72.78% (95% CI, 54.45 to 83.74, <i>p</i> = 0.0001): 26 cases per 15,298 (0.13 per 1,000 person-weeks) in MC versus 33 cases per 5,309 (0.46 per 1,000 person-weeks) in CC.</p><p><strong>Conclusion: </strong> The use of EP 30C was associated with some protection against probable and laboratory-confirmed dengue.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-09-20DOI: 10.1055/s-0044-1789000
Andrea Dei
{"title":"Homeopathy at a Turning Point.","authors":"Andrea Dei","doi":"10.1055/s-0044-1789000","DOIUrl":"https://doi.org/10.1055/s-0044-1789000","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142286068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-09-16DOI: 10.1055/s-0044-1788570
Edna Cristiane da Matta, Maristela Takeda, Nathalia Salles Scortegagna de Medeiros, Jorge Kioshi Hosomi, Leoni Villano Bonamin
{"title":"Homeopathy, Acupuncture and Phytotherapy in the Veterinary Treatment or Prophylaxis of Diseases in Animals: An Overview of Systematic Reviews","authors":"Edna Cristiane da Matta, Maristela Takeda, Nathalia Salles Scortegagna de Medeiros, Jorge Kioshi Hosomi, Leoni Villano Bonamin","doi":"10.1055/s-0044-1788570","DOIUrl":"https://doi.org/10.1055/s-0044-1788570","url":null,"abstract":"<p>\u0000<b>Introduction</b> Complementary and alternative veterinary medicine (CAVM) has been intensively used, and there is currently an increasing demand for a more rigorous approach regarding its clinical effectiveness.</p> <p>\u0000<b>Aims</b> The objectives of this overview were: first, to identify systematic reviews on homeopathy, acupuncture and phytotherapy in veterinary medicine and assess their methodological quality; and second, to map interventions and findings in the treatment or prophylaxis of any medical conditions in any animal species for which high-quality systematic reviews had identified reliable evidence of efficacy or effectiveness in randomized controlled trials (RCTs) or controlled clinical trials (CCTs).</p> <p>\u0000<b>Method</b> The study was an overview of systematic reviews published in the years 2000 to 2022 inclusive. The following databases were used: CAB Abstracts, PubMed and Vet Index, from which the abstracts of 173 articles were extracted, 22 of which were initially included for complete analysis. After excluding 15 studies according to the exclusion/inclusion criteria, 7 review papers were comprehensively analyzed. The review quality was assessed by the Measurement Tool to Assess Systematic Reviews (AMSTAR 2) method. The reported RCTs/CCTs in these reviews were analyzed for their reliability, and the results were classified according to statistical significance and risk of bias.</p> <p>\u0000<b>Results</b> Seven eligible systematic reviews reported studies on dogs, horses, cats, cattle, sheep, goats, swine, rabbits and poultry. The number of primary RCTs/CCTs was 38 for homeopathy, 35 for acupuncture, and 171 for phytotherapy. The AMSTAR 2 evaluation ranked two reviews of veterinary homeopathy as high-quality, in which two placebo-controlled RCTs comprised reliable evidence, one of which reported efficacy of homeopathy as prophylaxis for diarrhea in pigs. The systematic reviews of acupuncture and phytotherapy were all of low quality, preventing formal assessment of their reviewed RCTs/CCTs.</p> <p>\u0000<b>Conclusion</b> Only the systematic reviews of homeopathy were rated of sufficient quality to enable the assessment of reliable evidence within their reviewed RCTs. Contemporary high-quality systematic reviews of clinical trials in each of the three areas of CAVM are required.</p> ","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-09-09DOI: 10.1055/s-0044-1788921
Angelina J Mosley
{"title":"Pharmacoeconomic Study of Homeopathic Medicines: A Critical Appraisal of Methods and Conclusions Shows Serious Cause for Concern.","authors":"Angelina J Mosley","doi":"10.1055/s-0044-1788921","DOIUrl":"https://doi.org/10.1055/s-0044-1788921","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}